Bioinformatic approaches to investigate mechanisms driving the non-T cell-inflamed tumor microenvironment

被引:0
作者
Luke, Jason [1 ]
机构
[1] Univ Chicago Med, Chicago, IL USA
来源
JOURNAL OF TRANSLATIONAL MEDICINE | 2017年 / 15卷
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
K10
引用
收藏
页数:1
相关论文
共 50 条
[21]   DECREASED HOST PKC-DELTA IS ASSOCIATED WITH THE T CELL-INFLAMED TUMOR MICROENVIRONMENT AND IMPROVES ANTI-TUMOR IMMUNITY [J].
Cron, Kyle ;
Sivan, Ayelet ;
Aquino-Michaels, Keston ;
Higgs, Emily ;
Fessler, Jessica ;
Lee, Seoho ;
Sweis, Randy ;
Gajewski, Thomas .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 :A671-A671
[22]   Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors [J].
Bulgarelli, Jenny ;
Tazzari, Marcella ;
Granato, Anna Maria ;
Ridolfi, Laura ;
Maiocchi, Serena ;
de Rosa, Francesco ;
Petrini, Massimiliano ;
Pancisi, Elena ;
Gentili, Giorgia ;
Vergani, Barbara ;
Piccinini, Filippo ;
Carbonaro, Antonella ;
Leone, Biagio Eugenio ;
Foschi, Giovanni ;
Ancarani, Valentina ;
Framarini, Massimo ;
Guidoboni, Massimo .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[23]   Conversion of non-T cell-inflamed triple-negative breast cancer by in situ immunomodulation of induced intratumoral cross-presenting dendritic cells [J].
Oba, Takaaki ;
Keler, Tibor ;
Marsh, Henry C. ;
Abrams, Scott ;
Ito, Fumito .
CANCER RESEARCH, 2020, 80 (04)
[24]   Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer [J].
Sweis, Randy F. ;
Spranger, Stefani ;
Bao, Riyue ;
Paner, Gladell P. ;
Stadler, Walter M. ;
Steinberg, Gary ;
Gajewski, Thomas F. .
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (07) :563-568
[25]   Anlotinib Induces a T Cell-Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma [J].
Su, Yudong ;
Luo, Bingying ;
Lu, Yao ;
Wang, Daowei ;
Yan, Jie ;
Zheng, Jian ;
Xiao, Jun ;
Wang, Yangyang ;
Xue, Zhenyi ;
Yin, Jie ;
Chen, Peng ;
Li, Long ;
Zhao, Qiang .
CLINICAL CANCER RESEARCH, 2022, 28 (04) :793-809
[26]   The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment [J].
Gajewski, Thomas F. .
SEMINARS IN ONCOLOGY, 2015, 42 (04) :663-671
[27]   Difference of Tumor Mutational Burden Is Associated with Distinct Immune Microenviroment in the T Cell-Inflamed Lung Adenocarcinoma [J].
Karasaki, T. ;
Kitano, K. ;
Nagayama, K. ;
Nitadori, J. ;
Sato, M. ;
Anraku, M. ;
Kakimi, K. ;
Nakajima, J. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S423-S423
[28]   The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development [J].
Olson, Daniel J. ;
Luke, Jason J. .
IMMUNOTHERAPY, 2019, 11 (03) :155-159
[29]   IDENTIFICATION OF THE NON-T EFFECTOR CELL(S) MEDIATING TUMOR NEUTRALIZATION [J].
GOLDPOSEN, MH ;
LEWIS, DA ;
MILLER, GA ;
HOLYOKE, ED .
FEDERATION PROCEEDINGS, 1983, 42 (05) :1193-1193
[30]   Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response [J].
Garris, Christopher S. ;
Luke, Jason J. .
CLINICAL CANCER RESEARCH, 2020, 26 (15) :3901-3907